Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NCS Multistage Holdings (NCSM) Cash & Equivalents (2016 - 2025)

NCS Multistage Holdings (NCSM) has 10 years of Cash & Equivalents data on record, last reported at $36.7 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 41.9% year-over-year to $36.7 million; the TTM value through Dec 2025 reached $36.7 million, up 41.9%, while the annual FY2025 figure was $36.7 million, 41.9% up from the prior year.
  • Cash & Equivalents reached $36.7 million in Q4 2025 per NCSM's latest filing, up from $25.3 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $36.7 million in Q4 2025 and bottomed at $9.9 million in Q3 2022.
  • Average Cash & Equivalents over 5 years is $18.1 million, with a median of $15.9 million recorded in 2022.
  • The widest YoY moves for Cash & Equivalents: up 113.6% in 2021, down 55.54% in 2021.
  • A 5-year view of Cash & Equivalents shows it stood at $22.2 million in 2021, then decreased by 26.77% to $16.2 million in 2022, then rose by 2.99% to $16.7 million in 2023, then surged by 54.78% to $25.9 million in 2024, then skyrocketed by 41.9% to $36.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $36.7 million in Q4 2025, $25.3 million in Q3 2025, and $25.4 million in Q2 2025.